Robert Azelby Adc Therapeutics Sa (ADCT) insider trading activity
Robert Azelby is Director of ADC Therapeutics SA. Currently has a direct ownership of 53,005 shares of ADCT, which is worth approximately $156,364. The most recent transaction as insider was on Jun 17, 2024, when has been sold 6,995 shares (Common Shares) at a price of $2.89 per share, resulting in proceeds of $20,215. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
53K
0%
3M change
n/a
12M change
Total Value Held
$156,364
Robert Azelby Transaction History
Also insider at
RA
Robert Azelby
Director
Morris Plains, NJ